NCT05810402View on ClinicalTrials.gov

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

May 31, 2027

Conditions
Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaImmune Checkpoint InhibitorLiquid Biopsy
Interventions
BIOLOGICAL

Liquid Biopsy

"30mL blood sample:~* 1 x 10mL CellSave tube specifically designed for the collection and preservation of CTCs for CellSearch® analysis~* 1 EDTA tube for PBMCs isolation and circulating immune cells study (5mL),~* 2 EDTA tubes and 1 dry tube (15mL) for the preparation of the biobank (serum, plasma and cell)."

Trial Locations (1)

Unknown

RECRUITING

CHU Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER